Please use this identifier to cite or link to this item: http://repository.kln.ac.lk/handle/123456789/1579
Full metadata record
DC FieldValueLanguage
dc.contributor.authorKuruppuarachchi, K.A.L.A.en_US
dc.contributor.authorWilliams, S.S.en_US
dc.date.accessioned2014-10-29T09:21:50Zen_US
dc.date.available2014-10-29T09:21:50Zen_US
dc.date.issued2003en_US
dc.identifier.citationBritish Journal of Psychiatry.2003; 182(5): 455en_US
dc.identifier.issn0007-1250 (Print)en_US
dc.identifier.issn1472-1465 (Electronic)en_US
dc.identifier.urihttp://repository.kln.ac.lk/handle/123456789/1579en_US
dc.descriptionIndexed in MEDLINEen_US
dc.description.abstractComment on: McCreadie RG, Scottish Comorbidity Study Group. (Br J Psychiatry. 2002; 181:321-5).No abstract available.en_US
dc.publisherRoyal College of Psychiatristsen_US
dc.subjectAreca-adverse effectsen_US
dc.subjectSchizophrenia-diagnosisen_US
dc.subjectSubstance-Related Disorders-diagnosisen_US
dc.titleBetel use and schizophrenia.en_US
dc.typeLetteren_US
dc.identifier.departmentPsychiatryen_US
dc.creator.corporateauthorRoyal College of Psychiatristsen_US
Appears in Collections:Journal/Magazine Articles

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.